APA (7th ed.) Citation

N, A., E, A., C, M., F, B., S, L., C, C., . . . N, J. (2018). Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. Bioconjugate chemistry, 29(11), 3516. https://doi.org/10.1021/acs.bioconjchem.8b00668

Chicago Style (17th ed.) Citation

N, Aubrey, et al. "Site-Specific Conjugation of Auristatins onto Engineered ScFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro." Bioconjugate Chemistry 29, no. 11 (2018): 3516. https://doi.org/10.1021/acs.bioconjchem.8b00668.

MLA (9th ed.) Citation

N, Aubrey, et al. "Site-Specific Conjugation of Auristatins onto Engineered ScFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro." Bioconjugate Chemistry, vol. 29, no. 11, 2018, p. 3516, https://doi.org/10.1021/acs.bioconjchem.8b00668.